FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / PLoS One / Peripheral blood-derived mesenchymal stem cells demonstrate ...
PloS one2019; 14(3); e0212642; doi: 10.1371/journal.pone.0212642

Peripheral blood-derived mesenchymal stem cells demonstrate immunomodulatory potential for therapeutic use in horses.

Abstract: Previously, we showed that mesenchymal stem cells (MSC) can be mobilized into peripheral blood using electroacupuncture (EA) at acupoints, LI-4, LI-11, GV-14, and GV-20. The purpose of this study was to determine whether EA-mobilized MSC could be harvested and expanded in vitro to be used as an autologous cell therapy in horses. Peripheral blood mononuclear cells (PBMC) isolated from young and aged lame horses (n = 29) showed a marked enrichment for MSCs. MSC were expanded in vitro (n = 25) and administered intravenously at a dose of 50 x 106 (n = 24). Treatment resulted in significant improvement in lameness as assessed by the American Association of Equine Practitioners (AAEP) lameness scale (n = 23). MSCs exhibited immunomodulatory function by inhibition of lymphocyte proliferation and induction of IL-10. Intradermal testing showed no immediate or delayed immune reactions to MSC (1 x 106 to 1 x 104). In this study, we demonstrated an efficient, safe and reproducible method to mobilize and expand, in vitro, MSCs in sufficiently high concentrations for therapeutic administration. We confirm the immunomodulatory function of these cells in vitro. This non-pharmacological and non-surgical strategy for stem cell harvest has a broad range of biomedical applications and represents an improved clinically translatable and economical cell source for humans.
Get Full Text
Publication Date: 2019-03-14 PubMed ID: 30870461PubMed Central: PMC6417789DOI: 10.1371/journal.pone.0212642Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article
  • Research Support
  • N.I.H.
  • Extramural
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research demonstrates that it’s possible to mobilize, expand, and utilize mesenchymal stem cells (MSCs) from the peripheral blood of horses for therapeutic use, showing significant improvement in lameness. This could open new therapeutic implications and economical means for biomedical applications.

Research Background

  • Research interest existed in the potential therapeutic use of mesenchymal stem cells (MSCs) in horses.
  • Earlier studies had shown that MSCs could be mobilized into the peripheral blood using electroacupuncture (EA) at specific acupoints.

Study Purpose

  • The study aimed to determine if these EA-mobilized MSCs could be harvested, expanded in a lab setting, and used as an autologous cell therapy in horses. Autologous cell therapy refers to the process of re-infusing patient’s own cells after manipulation outside of the body.

Findings

  • A marked enrichment for MSCs was found when peripheral blood mononuclear cells (PBMC) were isolated from both young and aged lame horses.
  • The expanded MSCs were then administered intravenously to the horses and the resulting treatment led to a significant improvement in lameness, as assessed by the American Association of Equine Practitioners (AAEP) lameness scale.
  • The MSCs showed immunomodulatory function, which includes the ability to inhibit lymphocyte proliferation and the induction of the cytokine IL-10, an anti-inflammatory molecule.
  • Intradermal testing showed that there were no immediate or delayed immune reactions to the MSCs.

Implications

  • The finding suggests an efficient, safe and reproducible method to mobilize and expand MSCs in a lab setting in high enough concentrations for therapeutic administration.
  • The results confirmed the immunomodulatory function of the MSCs, which has potential implications for a range of biomedical applications.
  • This non-pharmacological and non-surgical method for harvesting stem cells may be a more clinically translatable and economical cell source compared to previous methods.
  • Given the shared evolutionary heritage between horses and humans, the findings potentially have broad significance for human medicine as well.

Cite This Article

APA
Longhini ALF, Salazar TE, Vieira C, Trinh T, Duan Y, Pay LM, Li Calzi S, Losh M, Johnston NA, Xie H, Kim M, Hunt RJ, Yoder MC, Santoro D, McCarrel TM, Grant MB. (2019). Peripheral blood-derived mesenchymal stem cells demonstrate immunomodulatory potential for therapeutic use in horses. PLoS One, 14(3), e0212642. https://doi.org/10.1371/journal.pone.0212642

Publication

PloS one
ISSN: 1932-6203
NlmUniqueID: 101285081
Country: United States
Language: English
Volume: 14
Issue: 3
Pages: e0212642

Researcher Affiliations

Longhini, Ana Leda F
  • Department of Ophthalmology and Visual Sciences, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
Salazar, Tatiana E
  • Department of Ophthalmology, Indiana University School of Medicine, Indianapolis, IN, United States of America.
Vieira, Cristiano
  • Department of Ophthalmology and Visual Sciences, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
Trinh, Thao
  • Department of Ophthalmology, Indiana University School of Medicine, Indianapolis, IN, United States of America.
Duan, Yaqian
  • Department of Ophthalmology, Indiana University School of Medicine, Indianapolis, IN, United States of America.
Pay, Louise M
  • Department of Ophthalmology, Indiana University School of Medicine, Indianapolis, IN, United States of America.
Li Calzi, Sergio
  • Department of Ophthalmology and Visual Sciences, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
Losh, Megan
  • Office of Vice President for Research, Indiana University, School of Medicine IACUC, Indianapolis, Indiana, United States of America.
Johnston, Nancy A
  • Laboratory Animal Resource Center, Indiana University, Indianapolis, Indiana, United States of America.
Xie, Huisheng
  • College of Veterinary Medicine, University of Florida, Gainesville, Florida, United States of America.
Kim, Minsu
  • Department of Clinical Science, College of Veterinary Medicine and Research Institute for Veterinary Science, Seoul National University, Seoul, Korea.
Hunt, Robert J
  • Hagyard Equine Medical Institute, Lexington, Kentucky, United States of America.
Yoder, Mervin C
  • Department of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana, United States of America.
Santoro, Domenico
  • College of Veterinary Medicine, University of Florida, Gainesville, Florida, United States of America.
McCarrel, Taralyn M
  • College of Veterinary Medicine, University of Florida, Gainesville, Florida, United States of America.
Grant, Maria B
  • Department of Ophthalmology and Visual Sciences, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.

MeSH Terms

  • Animals
  • Cell Proliferation
  • Cell Separation
  • Hematopoietic Stem Cell Mobilization
  • Horses
  • Immunomodulation
  • Lymphocytes / cytology
  • Lymphocytes / immunology
  • Mesenchymal Stem Cell Transplantation
  • Mesenchymal Stem Cells / cytology
  • Mesenchymal Stem Cells / immunology
  • Transplantation, Autologous

Grant Funding

  • R01 EY007739 / NEI NIH HHS
  • R01 EY012601 / NEI NIH HHS
  • R01 EY028037 / NEI NIH HHS
  • R01 HL110170 / NHLBI NIH HHS

Conflict of Interest Statement

The authors have declared that no competing interests exist.

References

This article includes 34 references
  1. Katsuda T, Kosaka N, Takeshita F, Ochiya T. The therapeutic potential of mesenchymal stem cell-derived extracellular vesicles. Proteomics 2013;13(10–11):1637–53.
    doi: 10.1002/pmic.201200373pubmed: 23335344google scholar: lookup
  2. Le Blanc K, Ringden O. Immunomodulation by mesenchymal stem cells and clinical experience. J Intern Med 2007;262(5):509–25.
    doi: 10.1111/j.1365-2796.2007.01844.xpubmed: 17949362google scholar: lookup
  3. Sangiorgi B, Panepucci RA. Modulation of Immunoregulatory Properties of Mesenchymal Stromal Cells by Toll-Like Receptors: Potential Applications on GVHD. Stem Cells Int 2016;2016:9434250.
    doi: 10.1155/2016/9434250pmc: PMC5050362pubmed: 27738438google scholar: lookup
  4. Crovace A, Lacitignola L, Rossi G, Francioso E. Histological and immunohistochemical evaluation of autologous cultured bone marrow mesenchymal stem cells and bone marrow mononucleated cells in collagenase-induced tendinitis of equine superficial digital flexor tendon. Vet Med Int 2010;2010:250978.
    doi: 10.4061/2010/250978pmc: PMC2859019pubmed: 20445779google scholar: lookup
  5. Godwin EE, Young NJ, Dudhia J, Beamish IC, Smith RK. Implantation of bone marrow-derived mesenchymal stem cells demonstrates improved outcome in horses with overstrain injury of the superficial digital flexor tendon. Equine Vet J 2012;44(1):25–32.
    doi: 10.1111/j.2042-3306.2011.00363.xpubmed: 21615465google scholar: lookup
  6. Smith RK, Korda M, Blunn GW, Goodship AE. Isolation and implantation of autologous equine mesenchymal stem cells from bone marrow into the superficial digital flexor tendon as a potential novel treatment. Equine Vet J 2003;35(1):99–102.
    pubmed: 12553472
  7. Ferris DJ, Frisbie DD, Kisiday JD, McIlwraith CW, Hague BA, Major MD. Clinical follow-up of horses treated with bone marrow-derived mesenchymal stem cells for musculoskeletal lesions. Lexington: American Association of Equine Practitioners (AAEP); 2009. p. 59–60.
  8. Kasashima Y, Ueno T, Tomita A, Goodship AE, Smith RK. Optimisation of bone marrow aspiration from the equine sternum for the safe recovery of mesenchymal stem cells. Equine Vet J 2011;43(3):288–94.
    doi: 10.1111/j.2042-3306.2010.00215.xpubmed: 21492205google scholar: lookup
  9. Metcalf GL, McClure SR, Hostetter JM, Martinez RF, Wang C. Evaluation of adipose-derived stromal vascular fraction from the lateral tailhead, inguinal region, and mesentery of horses. Can J Vet Res 2016;80(4):294–301.
    pmc: PMC5052881pubmed: 27733784
  10. Ahern BJ, Schaer TP, Terkhorn SP, Jackson KV, Mason NJ, Hankenson KD. Evaluation of equine peripheral blood apheresis product, bone marrow, and adipose tissue as sources of mesenchymal stem cells and their differentation potential. Am J Vet Res 2011;72(1):127–33.
    doi: 10.2460/ajvr.72.1.127pubmed: 21194345google scholar: lookup
  11. Salazar TE, Richardson MR, Beli E, Ripsch MS, George J, Kim Y. Electroacupuncture Promotes Central Nervous System-Dependent Release of Mesenchymal Stem Cells. Stem Cells 2017;35(5):1303–15.
    doi: 10.1002/stem.2613pmc: PMC5530374pubmed: 28299842google scholar: lookup
  12. Kimura K, Ryujin T, Uno M, Wakayama I. The Effect of Electroacupuncture with Different Frequencies on Muscle Oxygenation in Humans. Evidence-Based Complementary and Alternative Medicine 2015;2015:6.
    doi: 10.1155/2015/620785pmc: PMC4363685pubmed: 25821493google scholar: lookup
  13. Wei X, Du Z, Zhao L, Feng D, Wei G, He Y. IFATS collection: The conditioned media of adipose stromal cells protect against hypoxia-ischemia-induced brain damage in neonatal rats. Stem Cells 2009;27(2):478–88.
    doi: 10.1634/stemcells.2008-0333pubmed: 19023032google scholar: lookup
  14. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006;8(4):315–7.
    doi: 10.1080/14653240600855905pubmed: 16923606google scholar: lookup
  15. Keegan KG, Dent EV, Wilson DA, Janicek J, Kramer J, Lacarrubba A. Repeatability of subjective evaluation of lameness in horses. Equine Vet J 2010;42(2):92–7.
    doi: 10.2746/042516409X479568pubmed: 20156242google scholar: lookup
  16. Carrade DD, Affolter VK, Outerbridge CA, Watson JL, Galuppo LD, Buerchler S. Intradermal injections of equine allogeneic umbilical cord-derived mesenchymal stem cells are well tolerated and do not elicit immediate or delayed hypersensitivity reactions. Cytotherapy 2011;13(10):1180–92.
    doi: 10.3109/14653249.2011.602338pubmed: 21899391google scholar: lookup
  17. Wong DM, Buechner-Maxwell VA, Manning TO, Ward DL. Evaluation of the precision of intradermal injection of control substances for intradermal testing in clinically normal horses. Am J Vet Res 2005;66(8):1341–7.
    pubmed: 16173476
  18. Wong DM, Buechner-Maxwell VA, Manning TO, Ward DL. Comparison of results for intradermal testing between clinically normal horses and horses affected with recurrent airway obstruction. Am J Vet Res 2005;66(8):1348–55.
    pubmed: 16173477
  19. Seo JP, Tsuzuki N, Haneda S, Yamada K, Furuoka H, Tabata Y. Comparison of allogeneic platelet lysate and fetal bovine serum for in vitro expansion of equine bone marrow-derived mesenchymal stem cells. Res Vet Sci 2013;95(2):693–8.
    doi: 10.1016/j.rvsc.2013.04.024pubmed: 23683731google scholar: lookup
  20. Remacha AR, Barrachina L, Alvarez-Arguedas S, Ranera B, Romero A, Vazquez FJ. Expression of genes involved in immune response and in vitro immunosuppressive effect of equine MSCs. Vet Immunol Immunopathol 2015;165(3–4):107–18.
    doi: 10.1016/j.vetimm.2015.04.004pubmed: 25977164google scholar: lookup
  21. Broxmeyer HE, Orschell CM, Clapp DW, Hangoc G, Cooper S, Plett PA. Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist. J Exp Med 2005;201(8):1307–18.
    doi: 10.1084/jem.20041385pmc: PMC2213145pubmed: 15837815google scholar: lookup
  22. Kassis I, Zangi L, Rivkin R, Levdansky L, Samuel S, Marx G. Isolation of mesenchymal stem cells from G-CSF-mobilized human peripheral blood using fibrin microbeads. Bone Marrow Transplant 2006;37(10):967–76.
    doi: 10.1038/sj.bmt.1705358pubmed: 16670702google scholar: lookup
  23. Kumar S, Ponnazhagan S. Mobilization of bone marrow mesenchymal stem cells in vivo augments bone healing in a mouse model of segmental bone defect. Bone 2012;50(4):1012–8.
    doi: 10.1016/j.bone.2012.01.027pmc: PMC3339043pubmed: 22342795google scholar: lookup
  24. Kawada H, Fujita J, Kinjo K, Matsuzaki Y, Tsuma M, Miyatake H. Nonhematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction. Blood 2004;104(12):3581–7.
    doi: 10.1182/blood-2004-04-1488pubmed: 15297308google scholar: lookup
  25. Fukuda K, Miyata H, Kuwano A, Kuroda T, Tamura N, Kotoyori Y. Does the injection of platelet-rich plasma induce changes in the gene expression and morphology of intact Thoroughbred skeletal muscle?. J Equine Sci 2017;28(2):31–9.
    doi: 10.1294/jes.28.31pmc: PMC5506447pubmed: 28721121google scholar: lookup
  26. Luz-Crawford P, Kurte M, Bravo-Alegria J, Contreras R, Nova-Lamperti E, Tejedor G. Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells. Stem Cell Res Ther 2013;4(3):65.
    doi: 10.1186/scrt216pmc: PMC3706898pubmed: 23734780google scholar: lookup
  27. Zappia E, Casazza S, Pedemonte E, Benvenuto F, Bonanni I, Gerdoni E. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 2005;106(5):1755–61.
    doi: 10.1182/blood-2005-04-1496pubmed: 15905186google scholar: lookup
  28. Diez-Ruiz A, Tilz GP, Zangerle R, Baier-Bitterlich G, Wachter H, Fuchs D. Soluble receptors for tumour necrosis factor in clinical laboratory diagnosis. Eur J Haematol 1995;54(1):1–8.
    pubmed: 7859870
  29. Di Ianni M, Del Papa B, De Ioanni M, Moretti L, Bonifacio E, Cecchini D. Mesenchymal cells recruit and regulate T regulatory cells. Exp Hematol 2008;36(3):309–18.
    doi: 10.1016/j.exphem.2007.11.007pubmed: 18279718google scholar: lookup
  30. de Witte SFH, Luk F, Sierra Parraga JM, Gargesha M, Merino A, Korevaar SS. Immunomodulation By Therapeutic Mesenchymal Stromal Cells (MSC) Is Triggered Through Phagocytosis of MSC By Monocytic Cells. Stem Cells 2018;36(4):602–15.
    doi: 10.1002/stem.2779pubmed: 29341339google scholar: lookup
  31. Ghannam S, Pene J, Moquet-Torcy G, Jorgensen C, Yssel H. Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce a T regulatory cell phenotype. J Immunol 2010;185(1):302–12.
    doi: 10.4049/jimmunol.0902007pubmed: 20511548google scholar: lookup
  32. Carrade DD, Borjesson DL. Immunomodulation by mesenchymal stem cells in veterinary species. Comp Med 2013;63(3):207–17.
    pmc: PMC3690426pubmed: 23759523
  33. Corcione A, Benvenuto F, Ferretti E, Giunti D, Cappiello V, Cazzanti F. Human mesenchymal stem cells modulate B-cell functions. Blood 2006;107(1):367–72.
    doi: 10.1182/blood-2005-07-2657pubmed: 16141348google scholar: lookup
  34. Delling U, Lindner K, Ribitsch I, Julke H, Brehm W. Comparison of bone marrow aspiration at the sternum and the tuber coxae in middle-aged horses. Can J Vet Res 2012;76(1):52–6.
    pmc: PMC3244288pubmed: 22754095

Citations

This article has been cited 22 times.
  1. Zamlus ZI, Azman M, Lokanathan Y, Fauzi MB, Baki MM. Effects of Wharton's Jelly Mesenchymal Stem Cells and Its-Derived Small Extracellular Vesicles Loaded into Injectable Genipin-Crosslinked Gelatin Hydrogel on Vocal Fold Fibroblast. Polymers (Basel) 2025 Sep 30;17(19).
    doi: 10.3390/polym17192653pubmed: 41096299google scholar: lookup
  2. Fodor Duric L, Basic Jukic N, Vujicic B. Comparison of Autologous and Allogeneic Adipose-Derived Stem Cells in Kidney Transplantation: Immunological Considerations and Therapeutic Efficacy. J Clin Med 2024 Sep 27;13(19).
    doi: 10.3390/jcm13195763pubmed: 39407823google scholar: lookup
  3. Margiana R. Enhancing Spermatogenesis in Non-obstructive Azoospermia Through Mesenchymal Stem Cell Therapy22. Curr Stem Cell Res Ther 2024;19(11):1429-1441.
    doi: 10.2174/011574888X283311231226081845pubmed: 38243988google scholar: lookup
  4. Rivas IL, Soltero-Rivera M, Vapniarsky N, Arzi B. Stromal cell therapy in cats with feline chronic gingivostomatitis: current perspectives and future direction. J Feline Med Surg 2023 Aug;25(8):1098612X231185395.
    doi: 10.1177/1098612X231185395pubmed: 37548494google scholar: lookup
  5. Deng Z, Luo F, Lin Y, Luo J, Ke D, Song C, Xu J. Research trends of mesenchymal stem cells application in orthopedics: A bibliometric analysis of the past 2 decades. Front Public Health 2022;10:1021818.
    doi: 10.3389/fpubh.2022.1021818pubmed: 36225768google scholar: lookup
  6. Hart DA, Nakamura N. Creating an Optimal In Vivo Environment to Enhance Outcomes Using Cell Therapy to Repair/Regenerate Injured Tissues of the Musculoskeletal System. Biomedicines 2022 Jul 1;10(7).
    doi: 10.3390/biomedicines10071570pubmed: 35884875google scholar: lookup
  7. Voga M, Majdic G. Articular Cartilage Regeneration in Veterinary Medicine. Adv Exp Med Biol 2022;1401:23-55.
    doi: 10.1007/5584_2022_717pubmed: 35733035google scholar: lookup
  8. Pilgrim CR, McCahill KA, Rops JG, Dufour JM, Russell KA, Koch TG. A Review of Fetal Bovine Serum in the Culture of Mesenchymal Stromal Cells and Potential Alternatives for Veterinary Medicine. Front Vet Sci 2022;9:859025.
    doi: 10.3389/fvets.2022.859025pubmed: 35591873google scholar: lookup
  9. Xiang XN, Zhu SY, He HC, Yu X, Xu Y, He CQ. Mesenchymal stromal cell-based therapy for cartilage regeneration in knee osteoarthritis. Stem Cell Res Ther 2022 Jan 10;13(1):14.
    doi: 10.1186/s13287-021-02689-9pubmed: 35012666google scholar: lookup
  10. Xuan X, Tian C, Zhao M, Sun Y, Huang C. Mesenchymal stem cells in cancer progression and anticancer therapeutic resistance. Cancer Cell Int 2021 Nov 4;21(1):595.
    doi: 10.1186/s12935-021-02300-4pubmed: 34736460google scholar: lookup
  11. Rowland AL, Burns ME, Levine GJ, Watts AE. Preparation Technique Affects Recipient Immune Targeting of Autologous Mesenchymal Stem Cells. Front Vet Sci 2021;8:724041.
    doi: 10.3389/fvets.2021.724041pubmed: 34595230google scholar: lookup
  12. Wong CY. Current advances of stem cell-based therapy for kidney diseases. World J Stem Cells 2021 Jul 26;13(7):914-933.
    doi: 10.4252/wjsc.v13.i7.914pubmed: 34367484google scholar: lookup
  13. Sandonà M, Di Pietro L, Esposito F, Ventura A, Silini AR, Parolini O, Saccone V. Mesenchymal Stromal Cells and Their Secretome: New Therapeutic Perspectives for Skeletal Muscle Regeneration. Front Bioeng Biotechnol 2021;9:652970.
    doi: 10.3389/fbioe.2021.652970pubmed: 34095095google scholar: lookup
  14. Vieira CP, McCarrel TM, Grant MB. Novel Methods to Mobilize, Isolate, and Expand Mesenchymal Stem Cells. Int J Mol Sci 2021 May 27;22(11).
    doi: 10.3390/ijms22115728pubmed: 34072061google scholar: lookup
  15. Ansari S, Ito K, Hofmann S. Cell Sources for Human In vitro Bone Models. Curr Osteoporos Rep 2021 Feb;19(1):88-100.
    doi: 10.1007/s11914-020-00648-6pubmed: 33447910google scholar: lookup
  16. Lowry LE, Herzig MC, Christy BA, Schäfer R, Pati S, Cap AP, Bynum JA. Neglected No More: Emerging Cellular Therapies in Traumatic Injury. Stem Cell Rev Rep 2021 Aug;17(4):1194-1214.
    doi: 10.1007/s12015-020-10086-7pubmed: 33420590google scholar: lookup
  17. Kim SA, Park HY, Shin YW, Go EJ, Kim YJ, Kim YC, Shetty AA, Kim SJ. Hemovac blood after total knee arthroplasty as a source of stem cells. Ann Transl Med 2020 Nov;8(21):1406.
    doi: 10.21037/atm-20-2215pubmed: 33313151google scholar: lookup
  18. Jones WG, El-Jawhari JJ, Brockett CL, Koria L, Ktistakis I, Jones E. Multipotential stromal cells in the talus and distal tibia in ankle osteoarthritis - Presence, potency and relationships to subchondral bone changes. J Cell Mol Med 2021 Jan;25(1):259-271.
    doi: 10.1111/jcmm.15993pubmed: 33305883google scholar: lookup
  19. Voga M, Adamic N, Vengust M, Majdic G. Stem Cells in Veterinary Medicine-Current State and Treatment Options. Front Vet Sci 2020;7:278.
    doi: 10.3389/fvets.2020.00278pubmed: 32656249google scholar: lookup
  20. Abdelrazik H, Giordano E, Barbanti Brodano G, Griffoni C, De Falco E, Pelagalli A. Substantial Overview on Mesenchymal Stem Cell Biological and Physical Properties as an Opportunity in Translational Medicine. Int J Mol Sci 2019 Oct 29;20(21).
    doi: 10.3390/ijms20215386pubmed: 31671788google scholar: lookup
  21. Lotfy A, El-Sherbiny YM, Cuthbert R, Jones E, Badawy A. Comparative study of biological characteristics of mesenchymal stem cells isolated from mouse bone marrow and peripheral blood. Biomed Rep 2019 Oct;11(4):165-170.
    doi: 10.3892/br.2019.1236pubmed: 31565222google scholar: lookup
  22. Kornicka K, Geburek F, Röcken M, Marycz K. Stem Cells in Equine Veterinary Practice-Current Trends, Risks, and Perspectives. J Clin Med 2019 May 14;8(5).
    doi: 10.3390/jcm8050675pubmed: 31091732google scholar: lookup
Subscribe to our newsletter
Join 99,344 horse owners like you who receive our email updates on horse health and nutrition.